328 related articles for article (PubMed ID: 26420915)
1. Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.
Szatmári T; Ötvös R; Hjerpe A; Dobra K
Dis Markers; 2015; 2015():796052. PubMed ID: 26420915
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Expression of Syndecan-1 in Cervical Cancers.
Karászi K; Vigh R; Máthé M; Fullár A; Oláh L; Füle T; Papp Z; Kovalszky I
Pathol Oncol Res; 2020 Oct; 26(4):2255-2264. PubMed ID: 32388727
[TBL] [Abstract][Full Text] [Related]
3. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.
Götte M; Kersting C; Radke I; Kiesel L; Wülfing P
Breast Cancer Res; 2007; 9(1):R8. PubMed ID: 17244359
[TBL] [Abstract][Full Text] [Related]
4. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 (CD138), Carcinomas and EMT.
Couchman JR
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921767
[TBL] [Abstract][Full Text] [Related]
6. A cytoplasmic C-terminal fragment of Syndecan-1 is generated by sequential proteolysis and antagonizes Syndecan-1 dependent lung tumor cell migration.
Pasqualon T; Pruessmeyer J; Jankowski V; Babendreyer A; Groth E; Schumacher J; Koenen A; Weidenfeld S; Schwarz N; Denecke B; Jahr H; Dreymueller D; Jankowski J; Ludwig A
Oncotarget; 2015 Oct; 6(31):31295-312. PubMed ID: 26378057
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.
Szatmári T; Mundt F; Kumar-Singh A; Möbus L; Ötvös R; Hjerpe A; Dobra K
BMC Cell Biol; 2017 Dec; 18(1):34. PubMed ID: 29216821
[TBL] [Abstract][Full Text] [Related]
8. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.
Akl MR; Nagpal P; Ayoub NM; Prabhu SA; Gliksman M; Tai B; Hatipoglu A; Goy A; Suh KS
Oncotarget; 2015 Oct; 6(30):28693-715. PubMed ID: 26293675
[TBL] [Abstract][Full Text] [Related]
10. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.
Szumilo J; Burdan F; Zinkiewicz K; Dudka J; Klepacz R; Dabrowski A; Korobowicz E
Folia Histochem Cytobiol; 2009; 47(4):571-8. PubMed ID: 20430722
[TBL] [Abstract][Full Text] [Related]
11. Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.
Stewart MD; Ramani VC; Sanderson RD
J Biol Chem; 2015 Jan; 290(2):941-9. PubMed ID: 25404732
[TBL] [Abstract][Full Text] [Related]
12. CD138 (syndecan-1) expression in health and disease.
Palaiologou M; Delladetsima I; Tiniakos D
Histol Histopathol; 2014 Feb; 29(2):177-89. PubMed ID: 24150912
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
14. Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?
Giordano RJ
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):716-8. PubMed ID: 18528290
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.
Hassan H; Greve B; Pavao MS; Kiesel L; Ibrahim SA; Götte M
FEBS J; 2013 May; 280(10):2216-27. PubMed ID: 23289672
[TBL] [Abstract][Full Text] [Related]
16. The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors.
Szatmári T; Dobra K
Front Oncol; 2013 Dec; 3():310. PubMed ID: 24392351
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
Wei HT; Guo EN; Dong BG; Chen LS
BMC Gastroenterol; 2015 Oct; 15():152. PubMed ID: 26518017
[TBL] [Abstract][Full Text] [Related]
18. Molecular functions of syndecan-1 in disease.
Teng YH; Aquino RS; Park PW
Matrix Biol; 2012 Jan; 31(1):3-16. PubMed ID: 22033227
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis.
Zhang X; Wu C; Song J; Götte M; Sorokin L
J Immunol; 2013 Nov; 191(9):4551-61. PubMed ID: 24078687
[TBL] [Abstract][Full Text] [Related]
20. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
